cdmo.directory
← Compare landing

Rentschler Biopharma SE vs Xcellon Biologics

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryRentschler Biopharma SEXcellon Biologics
SummaryRentschler Biopharma is a family-owned CDMO offering bioprocess development and manufacturing of biopharmaceuticals, with about 50 years of experience. It operates sites in Laupheim, Germany and Milford, Massachusetts, USA.Maryland-based CDMO for complex biologics, including antibody-drug conjugates, bispecific antibodies, and T-cell engagers. Services span bioconjugation, bioprocess and analytical/formulation development, CGMP manufacturing, and in vivo pharmacology.
Services
  • Regulatory Affairs
  • Analytical Method Development & Validation
  • Biologics Development & Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Process Development
  • Formulation Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
  • Discovery Research
  • Protein Engineering
  • Preclinical In Vivo Studies
  • Bioanalysis
  • Analytical Method Development & Validation
  • Biologics Development & Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Bioconjugation Services
  • Process Development
  • Formulation Development
Modalities
  • Biologics (Other)
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
Development capabilities
  • Analytical method development
  • Formulation development
  • Analytical method development
  • Formulation development
Manufacturing capabilitiesData not yet provided.Data not yet provided.
Locations
  • Headquarters, Laupheim, Baden-Württemberg, Germany
  • Milford, Milford, Massachusetts, USA
  • Maryland, Maryland, United States
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Rentschler Biopharma SE alternatives · Xcellon Biologics alternatives

Markdown mirror: /compare/rentschler-biopharma/xcellon.md